Transfusion strategies for traumatic coagulopathy.

Abstract:

:Uncontrolled bleeding is the most common preventable cause of death for patients with severe injury. Coagulopathy inevitably accompanies severe bleeding, exacerbated by the ongoing blood loss and the treatments administered. There is debate about the underlying pathophysiological mechanisms of early traumatic coagulopathy and uncertainty about whether injury induces a unique coagulopathy when compared to other forms of major haemorrhage. This review describes current understanding of the coagulopathy of major blood loss and focuses on the early coagulation changes that occur following severe injury. It then reports on the contemporary management of coagulopathic bleeding using new transfusion strategies. Finally this review presents some practical points to the delivery of transfusion for major blood loss in the modern hospital setting.

journal_name

Blood Rev

journal_title

Blood reviews

authors

Curry NS,Davenport RA,Hunt BJ,Stanworth SJ

doi

10.1016/j.blre.2012.06.004

subject

Has Abstract

pub_date

2012-09-01 00:00:00

pages

223-32

issue

5

eissn

0268-960X

issn

1532-1681

pii

S0268-960X(12)00048-3

journal_volume

26

pub_type

杂志文章,评审
  • Splenomegaly: investigation, diagnosis and management.

    abstract::Splenomegaly is a feature of a broad range of diseases, and presents to clinicians in many fields. This review examines the aetiology of splenomegaly in the developed world, and describes a logical approach to the patient with splenomegaly. In some patients, extensive radiological and laboratory investigations will fa...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2008.10.001

    authors: Pozo AL,Godfrey EM,Bowles KM

    更新日期:2009-05-01 00:00:00

  • Optimizing platelet transfusion therapy.

    abstract::Platelet transfusions are widely used. Prophylactic transfusions are employed in severely thrombocytopenic patients without evidence of bleeding, but no randomized trial data prove the safety or efficacy of this approach. Randomized trials have demonstrated the equivalence of transfusion triggers of 10,000 and 20,000/...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/S0268-960X(03)00057-2

    authors: Heal JM,Blumberg N

    更新日期:2004-09-01 00:00:00

  • Treatment of musculo-skeletal pain in haemophilia.

    abstract::Musculo-skeletal pain treatment is inadequate in many haemophilic patients. Analgesics are used only by 36% of adult patients. FVIII/FIX intravenous infusion is mainly used to lessen pain, followed in frequency by usage of NSAIDS (primarily COX-2 inhibitors). In about 30% of patients, pain continues after infusion of ...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2017.09.004

    authors: Rodriguez-Merchan EC

    更新日期:2018-03-01 00:00:00

  • Optimal management of older patients with chronic lymphocytic leukemia: some facts and principles guiding therapeutic choices.

    abstract::Chronic lymphocytic leukemia (CLL) is a disease of older patients and median age at diagnosis is 72 years. This older group is under-represented in clinical trials, (median age 58-62 years). Here we review background data on incidence, survival, definitions of older age, fitness criteria, frailty and co-morbidities. I...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2011.09.002

    authors: Tadmor T,Polliack A

    更新日期:2012-01-01 00:00:00

  • Targeting platelet receptor function in thrombus formation: the risk of bleeding.

    abstract::In this review, we presume that the process of thrombus formation, as assessed in whole blood flow studies and in experimental (murine) thrombosis studies, reflects the platelet responses in human haemostasis and thrombosis. Following this concept, we give an up-to-date overview of the main platelet receptors and sign...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2013.12.001

    authors: Swieringa F,Kuijpers MJ,Heemskerk JW,van der Meijden PE

    更新日期:2014-01-01 00:00:00

  • Transfusion-associated graft-versus-host disease and its prevention.

    abstract::Transfusion-associated graft-versus-host disease is a rare but usually fatal complication of transfusion of cellular blood components, caused by multiorgan engraftment and proliferation of donor T lymphocytes. The classical features of skin rash, diarrhoea and hepatitis, along with striking bone-marrow failure, are se...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0268-960x(95)90016-0

    authors: Williamson LM,Warwick RM

    更新日期:1995-12-01 00:00:00

  • Platelet activation markers in evaluation of thrombotic risk factors in various clinical settings.

    abstract::Platelets play a major role in primary hemostasis and thrombus formation. After vascular injury, platelets adhere to injured site and rapidly change their shape that switches the resting platelets to active state. Activated platelets aggregate and secrete biologically active intermediate substances that further potent...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2019.05.007

    authors: Kannan M,Ahmad F,Saxena R

    更新日期:2019-09-01 00:00:00

  • Veno-occlusive disease: cytokines, genetics, and haemostasis.

    abstract::Hepatic veno-occlusive disease (VOD) is a major cause of morbidity and mortality following high dose cytotoxic therapy for stem cell transplantation (SCT). Pre-existing liver damage, SCT-related therapy, and genetic polymorphisms all appear to increase the risk of developing VOD. Studies of biological markers during S...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0268-960x(03)00002-x

    authors: Coppell JA,Brown SA,Perry DJ

    更新日期:2003-06-01 00:00:00

  • Mechanisms of extramedullary relapse in acute lymphoblastic leukemia: Reconciling biological concepts and clinical issues.

    abstract::Long-term survival rates in childhood acute lymphoblastic leukemia (ALL) are currently above 85% due to huge improvements in treatment. However, 15-20% of children still experience relapses. Relapses can either occur in the bone marrow or at extramedullary sites, such as gonads or the central nervous system (CNS), for...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2019.04.003

    authors: Gaudichon J,Jakobczyk H,Debaize L,Cousin E,Galibert MD,Troadec MB,Gandemer V

    更新日期:2019-07-01 00:00:00

  • The role of pentostatin (2'-deoxycoformycin, dCF) in the management of lymphoproliferative malignancies.

    abstract::Laboratory and clinical data relating to the use of 2'-deoxycoformycin in human disease are reviewed. Pentostatin is an inhibitor of adenosine deaminase, an enzyme that is important for purine metabolism, but more than one mechanism may be involved in its cytotoxic action. Early studies with dCF employed large doses a...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(87)90004-x

    authors: Spiers AS

    更新日期:1987-06-01 00:00:00

  • Molecular diagnosis of haematological neoplasms.

    abstract::DNA analysis has become of practical value in the diagnosis and classification of leukaemias and lymphomas. This is exemplified by the study of lymphoproliferative disorders using immunoglobulin and T-cell receptor gene probes for the determination of clonality and cell lineage. Chromosomal analysis with DNA probes is...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(88)90028-8

    authors: Fey MF,Wainscoat JS

    更新日期:1988-06-01 00:00:00

  • Childhood immune thrombocytopenic purpura.

    abstract::Childhood immune thrombocytopenic purpura (ITP) is acute and generally seasonal in nature, suggesting that infectious or environmental agents may trigger the immune response to produce platelet-reactive autoantibodies 4 to 8 weeks following an infection. In general, the patient is well apart from the diffuse bruising ...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1054/blre.2001.0177

    authors: Nugent DJ

    更新日期:2002-03-01 00:00:00

  • The golden age for patients in their golden years: The progressive upheaval of age and the treatment of newly-diagnosed acute myeloid leukemia.

    abstract::Most acute myeloid leukemia (AML) patients will be aged more than 65 years. Chronological aging is accompanied by decreasing stem cell and solid organ reserve as well as an increased incidence of medical comorbidity. For the older patient with AML, these patient-specific factors are compounded by an association with c...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2019.100639

    authors: Shallis RM,Boddu PC,Bewersdorf JP,Zeidan AM

    更新日期:2020-03-01 00:00:00

  • Screening and genetic diagnosis of haemoglobin disorders.

    abstract::The inherited haemoglobinopathies are large group of disorders that include the thalassaemias and sickle cell disease. Carrier detection methods must be able to detect alpha-, beta- and deltabeta-thalassaemias, HPFH disorders and haemoglobin variants. Carrier diagnosis involves the accurate measurement of MCH, MCV, Hb...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0268-960x(02)00061-9

    authors: Old JM

    更新日期:2003-03-01 00:00:00

  • Treatment of newly diagnosed advanced stage Hodgkin lymphoma.

    abstract::ABVD continues to be the standard of care for patients with advanced stage Hodgkin Lymphoma (HL) although escalated BEACOPP has improved survival in one randomized controlled trial (RCT). More intensive regimens have higher rates of acute and late toxicities and this poses significant issues for patients. Consolidatio...

    journal_title:Blood reviews

    pub_type: 杂志文章,随机对照试验,评审

    doi:10.1016/j.blre.2012.04.001

    authors: Uhm J,Kuruvilla J

    更新日期:2012-07-01 00:00:00

  • Myelodysplasic syndromes: a comprehensive review.

    abstract::Myelodysplastic syndromes (MDS) are a set of oligoclonal disorders of hematopoietic stem cells characterized by ineffective hematopoiesis that manifest clinically as anemia, neutropenia, and/or thrombocytopenia of variable severity. The result often is transfusion-dependent anemia, an increased risk of infection or he...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2005.01.004

    authors: Catenacci DV,Schiller GJ

    更新日期:2005-11-01 00:00:00

  • The unstable haemoglobins.

    abstract::The unstable haemoglobin haemolytic anaemias result from the presence in the red cell of a structurally abnormal haemoglobin variant. There are many mutations producing unstable haemoglobins; most are single amino acid replacements that affect a few key areas of the haemoglobin structure. A wide range of haemoglobin i...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(93)90002-l

    authors: Williamson D

    更新日期:1993-09-01 00:00:00

  • Idiopathic myelofibrosis: historical review, diagnosis and management.

    abstract::Idiopathic myelofibrosis is reviewed from several aspects. The historical development of knowledge about this disorder is discussed, from early descriptions of extramedullary hematopoiesis associated with numerous etiologies, a debate over pathogenetic mechanisms, followed by newer evidence which placed this disorder ...

    journal_title:Blood reviews

    pub_type: 历史文章,杂志文章,评审

    doi:10.1016/0268-960x(91)90041-a

    authors: Weinstein IM

    更新日期:1991-06-01 00:00:00

  • Hepcidin and anaemia.

    abstract::The anaemia of chronic disease (ACD) is a common haematologic syndrome characterized by hypoferraemia with adequate reticuloendothelial iron stores. Frequently, serum ferritin concentration in these patients is elevated. The pathogenesis of ACD involves abnormalities in red cell survival, the erythropoietic response t...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/S0268-960X(03)00066-3

    authors: Means RT Jr

    更新日期:2004-12-01 00:00:00

  • Management of challenging myelofibrosis after JAK inhibitor failure and/or progression.

    abstract::The myeloproliferative neoplasms (MPNs) encompass a heterogenous set of diseases that have variable survival, but in the setting of treatment refractory and progressive disease, prognosis has been characteristically poor. JAK inhibition with ruxolitinib or fedratinib therapy has become the first line treatment for sym...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2020.100716

    authors: Scherber RM,Mesa RA

    更新日期:2020-07-01 00:00:00

  • Duration of anticoagulation: decision making based on absolute risk.

    abstract::We are often faced with the question as to the optimum duration of secondary prophylaxis with oral anticoagulants after an episode of venous thromboembolism. Theoretically if we know the recurrence rate, the case-fatality, the effectiveness of oral anticoagulant therapy, and the rate of fatal haemorrhage on treatment,...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2005.09.001

    authors: Keeling D

    更新日期:2006-05-01 00:00:00

  • Transfusions for anemia in adult and pediatric patients with malignancies.

    abstract::Anemia is present in over two-thirds of patients with malignant hematological disorders. The etiology of anemia predominates from ineffective erythropoiesis from marrow infiltration, cytokine related suppression, erythropoietin suppression, and vitamin deficiency; ineffective erythropoiesis is further exacerbated by a...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2015.02.001

    authors: Shah N,Andrews J,Goodnough LT

    更新日期:2015-09-01 00:00:00

  • Modifying perioperative blood loss.

    abstract::Fears about the risks of disease transmission through the transfusion of homologous blood, as well as problems with blood supply and cost have increased the interest in reducing perioperative bleeding. This article discusses the causes of non-surgical perioperative bleeding and attempts to reduce perioperative bleedin...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(91)90034-a

    authors: Hunt BJ

    更新日期:1991-09-01 00:00:00

  • The role of unrelated bone-marrow transplantation in childhood acute leukaemia.

    abstract::Early reports would suggest that closely matched UD BMT is an adequate substitute for MSD BMT in children with relapsed ALL. Protagonists of BMT might suggest that UD BMT be used in the absence of a MSD in all cases of BM relapse of ALL. However, recent improvements in chemoradiotherapy schedules have reduced the bene...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/s0268-960x(96)90006-5

    authors: Veys P

    更新日期:1996-12-01 00:00:00

  • Antithrombin III deficiency.

    abstract::A moderate reduction of plasma antithrombin activity is an uncommon but clinically important cause of severe thromboembolic disease. In recent years the molecule responsible for the major part of this activity (antithrombin III) has been extensively characterised and the mode of inheritance of familial deficiencies wo...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/0268-960x(88)90013-6

    authors: Beresford CH

    更新日期:1988-12-01 00:00:00

  • Hemophagocytic syndromes.

    abstract::Hemophagocytic syndromes (hemophagocytic lymphohistiocytosis, HLH) represent a severe hyperinflammatory condition with the cardinal symptoms prolonged fever, cytopenias, hepatosplenomegaly, and hemophagocytosis by activated, morphologically benign macrophages. Biochemical markers include elevated ferritin and triglyce...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2007.05.001

    authors: Janka GE

    更新日期:2007-09-01 00:00:00

  • Disorders of oxidised haemoglobin.

    abstract::Methaemoglobinaemia arises from the production of non-functional haemoglobin containing oxidised Fe(3+) which results in reduced oxygen supply to the tissues and manifests as cyanosis in the patient. It can develop by three distinct mechanisms: genetic mutation resulting in the presence of abnormal haemoglobin, a defi...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2004.02.001

    authors: Percy MJ,McFerran NV,Lappin TR

    更新日期:2005-03-01 00:00:00

  • Resuscitation and transfusion principles for traumatic hemorrhagic shock.

    abstract::The transfusion approach to massive hemorrhage has continually evolved since it began in the early 1900s. It started with fresh whole blood and currently consists of virtually exclusive use of component and crystalloid therapy. Recent US military experience has reinvigorated the debate on what the most optimal transfu...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2009.07.003

    authors: Spinella PC,Holcomb JB

    更新日期:2009-11-01 00:00:00

  • Venous thromboembolism incidence in hematologic malignancies.

    abstract::Venous thromboembolism (VTE) remains a major cause of morbidity and mortality in patients with cancer. Although some very well validated scores delineate the risk of VTE by cancer subtype and other risk factors, hematologic malignancies are underrepresented in these models. This subgroup represents a unique entity tha...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2018.06.002

    authors: Kekre N,Connors JM

    更新日期:2019-01-01 00:00:00

  • Neutrophil extracellular traps (NETs) and infection-related vascular dysfunction.

    abstract::The innate immune system orchestrated by leukocytes primarily neutrophils, serves to remove dead and dying host cells and to provide protection against invasion by pathogens. Failure of this system results in the onset of sepsis leading to grave consequences for the host. Together with mechanical methods to physically...

    journal_title:Blood reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.blre.2012.09.001

    authors: Gardiner EE,Andrews RK

    更新日期:2012-11-01 00:00:00